Point of Care Molecular Diagnostics -Global Market Status and Trend Report 2013-2023

Table of Contents

Chapter 1 Overview of Point of Care Molecular Diagnostics

• 1.1 Definition of Point of Care Molecular Diagnostics in This Report
• 1.2 Commercial Types of Point of Care Molecular Diagnostics
  • 1.2.1 Assays and Kits
  • 1.2.2 Instruments or Analyzers
  • 1.2.3 Services and Software
• 1.3 Downstream Application of Point of Care Molecular Diagnostics
  • 1.3.1 Respiratory Diseases
  • 1.3.2 Sexually Transmitted Diseases
  • 1.3.3 Hospital-acquired Infection
  • 1.3.4 Oncology
  • 1.3.5 Hepatitis
  • 1.3.6 Others
• 1.4 Development History of Point of Care Molecular Diagnostics
• 1.5 Market Status and Trend of Point of Care Molecular Diagnostics 2013-2023
  • 1.5.1 Global Point of Care Molecular Diagnostics Market Status and Trend 2013-2023
  • 1.5.2 Regional Point of Care Molecular Diagnostics Market Status and Trend 2013-2023

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Point of Care Molecular Diagnostics 2013-2017
• 2.2 Production Market of Point of Care Molecular Diagnostics by Regions
  • 2.2.1 Production Volume of Point of Care Molecular Diagnostics by Regions
  • 2.2.2 Production Value of Point of Care Molecular Diagnostics by Regions
• 2.3 Demand Market of Point of Care Molecular Diagnostics by Regions
• 2.4 Production and Demand Status of Point of Care Molecular Diagnostics by Regions
  • 2.4.1 Production and Demand Status of Point of Care Molecular Diagnostics by Regions 2013-2017
  • 2.4.2 Import and Export Status of Point of Care Molecular Diagnostics by Regions 2013-2017

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Point of Care Molecular Diagnostics by Types
• 3.2 Production Value of Point of Care Molecular Diagnostics by Types
• 3.3 Market Forecast of Point of Care Molecular Diagnostics by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Point of Care Molecular Diagnostics by Downstream Industry
• 4.2 Market Forecast of Point of Care Molecular Diagnostics by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Point of Care Molecular Diagnostics

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Point of Care Molecular Diagnostics Downstream Industry Situation and Trend Overview

Chapter 6 Point of Care Molecular Diagnostics Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Point of Care Molecular Diagnostics by Major Manufacturers
• 6.2 Production Value of Point of Care Molecular Diagnostics by Major Manufacturers
• 6.3 Basic Information of Point of Care Molecular Diagnostics by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Point of Care Molecular Diagnostics Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Point of Care Molecular Diagnostics Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Point of Care Molecular Diagnostics Major Manufacturers Introduction and Market Data

• 7.1 Myriad Genetics
  • 7.1.1 Company profile
  • 7.1.2 Representative Point of Care Molecular Diagnostics Product
  • 7.1.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Myriad Genetics
• 7.2 Cepheid
  • 7.2.1 Company profile
  • 7.2.2 Representative Point of Care Molecular Diagnostics Product
  • 7.2.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid
• 7.3 Illumina Inc.
  • 7.3.1 Company profile
  • 7.3.2 Representative Point of Care Molecular Diagnostics Product
  • 7.3.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Illumina Inc.
• 7.4 Abbott
  • 7.4.1 Company profile
  • 7.4.2 Representative Point of Care Molecular Diagnostics Product
  • 7.4.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott
• 7.5 Agilent Technologies Inc.
  • 7.5.1 Company profile
  • 7.5.2 Representative Point of Care Molecular Diagnostics Product
  • 7.5.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Agilent Technologies Inc.
• 7.6 Hoffmann-La Roche Ltd.
  • 7.6.1 Company profile
  • 7.6.2 Representative Point of Care Molecular Diagnostics Product
  • 7.6.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche Ltd.
• 7.7 GenePOC Inc.
  • 7.7.1 Company profile
  • 7.7.2 Representative Point of Care Molecular Diagnostics Product
  • 7.7.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of GenePOC Inc.
• 7.8 QIAGEN
  • 7.8.1 Company profile
  • 7.8.2 Representative Point of Care Molecular Diagnostics Product
  • 7.8.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN
• 7.9 Hologic Inc.
  • 7.9.1 Company profile
  • 7.9.2 Representative Point of Care Molecular Diagnostics Product
  • 7.9.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc.
• 7.10 Genomic Health
  • 7.10.1 Company profile
  • 7.10.2 Representative Point of Care Molecular Diagnostics Product
  • 7.10.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Genomic Health
• 7.11 Beckman Coulter Inc
  • 7.11.1 Company profile
  • 7.11.2 Representative Point of Care Molecular Diagnostics Product
  • 7.11.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter Inc
• 7.12 Siemens Healthcare GmbH
  • 7.12.1 Company profile
  • 7.12.2 Representative Point of Care Molecular Diagnostics Product
  • 7.12.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare GmbH
• 7.13 DxNA LLC.
  • 7.13.1 Company profile
  • 7.13.2 Representative Point of Care Molecular Diagnostics Product
  • 7.13.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DxNA LLC.
• 7.14 Abaxis, Bayer AG,
  • 7.14.1 Company profile
  • 7.14.2 Representative Point of Care Molecular Diagnostics Product
  • 7.14.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis, Bayer AG,
• 7.15 Johnson & Johnson Services Inc.
  • 7.15.1 Company profile
  • 7.15.2 Representative Point of Care Molecular Diagnostics Product
  • 7.15.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services Inc.
• 7.16 Biocartis
• 7.17 Binx Health Inc.
• 7.18 Grifols S.A.
• 7.19 Medtronic
• 7.20 Spartan Bioscience Inc.
• 7.21 Quidel Corporation
• 7.22 bioMérieux SA
• 7.23 Sysmex Corporation
• 7.24 BD
• 7.25 OraSure Technologies Inc.
• 7.26 Bio-Rad Laboratories Inc.
• 7.27 Meridian Bioscience Inc.
• 7.28 Danaher

Chapter 8 Upstream and Downstream Market Analysis of Point of Care Molecular Diagnostics

• 8.1 Industry Chain of Point of Care Molecular Diagnostics
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Point of Care Molecular Diagnostics

• 9.1 Cost Structure Analysis of Point of Care Molecular Diagnostics
• 9.2 Raw Materials Cost Analysis of Point of Care Molecular Diagnostics
• 9.3 Labor Cost Analysis of Point of Care Molecular Diagnostics
• 9.4 Manufacturing Expenses Analysis of Point of Care Molecular Diagnostics

Chapter 10 Marketing Status Analysis of Point of Care Molecular Diagnostics

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources